U
Silo Wellness Inc. SILO
CNSX
Recommendation
Prev Close
$0.01
Volume
--
Avg Vol (90D)
0
Market Cap
$1.11M
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$0.1239
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Silo Pharma files to sell $4.72M shares of common stock, warrants
4/25/2025 - SeekingAlpha.com: All News
Silo Pharma files to sell 4.72M shares of common stock, warrants
4/25/2025 - TipRanks Financial Blog
Silo Pharma files to sell 4.72M shares of common stock, warrants
4/25/2025 - The Fly
Silo Pharma (NASDAQ:SILO) Announces Quarterly Earnings Results
3/30/2025 - Ticker Report
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a ...
3/26/2025 - GuruFocus
Silo Pharma announces first dosing in IND-enabling study for SPC-15
3/26/2025 - The Fly
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
3/26/2025 - Globe Newswire
Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
2/26/2025 - GuruFocus
Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
2/26/2025 - Globe Newswire
Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for ...
2/18/2025 - GuruFocus
Silo Pharma files provisional patent for SPC-15 combination
2/18/2025 - The Fly
Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
2/18/2025 - Globe Newswire
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 80.4% in January
2/13/2025 - Ticker Report
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 ...
2/11/2025 - GuruFocus
Silo Pharma announces initial data from SP-26 study
2/11/2025 - The Fly
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
2/11/2025 - Globe Newswire
Silo Pharma (NASDAQ:SILO) Trading Up 1.2% - Here's Why
2/6/2025 - Ticker Report
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD ...
1/22/2025 - GuruFocus
Silo Pharma announces provisional patent filing for PTSD treatment
1/22/2025 - The Fly
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
1/22/2025 - Globe Newswire
Silo Pharma Shares Are Surging Today: What's Going On?
1/8/2025 - Benzinga
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 ...
1/8/2025 - GuruFocus
Silo Pharma awarded U.S. patent for PTSD treatment
1/8/2025 - The Fly
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
1/8/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$275.80K
EBITDA (TTM)
-$3.08M
EBIT (TTM)
-$3.85M
Net Income (TTM)
$507.70K
Balance Sheet
Total Assets (Q)
$62.90K
Total Debt (Q)
$837.20K
Total Liabilities (Q)
$1.83M
Book Value Per Share (Q)
-$0.0114
Cash Flow
Cash from Operations (TTM)
-$152.40K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$73.00K
Net Change in Cash (TTM)
-$169.90K
Filings
Filing Date
Friday, September 29, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)
Price History
Loading...
Beta
0.86
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
0.00%
Year to Date Total Return
0.00%
1-Year Total Return
0.00%
2-Year Total Return
-60.00%
3-Year Total Return
-97.50%
5-Year Total Return
--
52-week Low
Apr 25, 2025 - --
52-week High
Apr 25, 2025 - --
Valuation
Market Cap
$1.11M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
5.56
Price/Book (Q)
-0.88
Dividends and Shares
Shares Outstanding
147.62M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.silowellness.com
Phone Number
541-900-5871
Address
200 Consumers Road
Toronto, ON M2J 4R4
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Silo Wellness Inc., a psychedelics and wellness company, develops psychedelic medicine to reduce trauma. The company develops and sells psilocybin-free functional mushroom tinctures; and the... more